These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7035306)

  • 1. Increased release of vascular prostacyclin-like activity after long-term treatment of diabetic rats with Bay g 6575.
    Chamone DA; van Damme B; Carreras LO; Vermylen J
    Haemostasis; 1981; 10(6):297-303. PubMed ID: 7035306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound Bay g 6575.
    Carreras LO; Chamone DA; Klerckx P; Vermylen J
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):663-70. PubMed ID: 7003804
    [No Abstract]   [Full Text] [Related]  

  • 3. Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall.
    Klitzke AK
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):220-8. PubMed ID: 6391401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H; Williams P
    J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).
    Honn KV; Meyer J; Neagos G; Henderson T; Westley C; Ratanatharathorn V
    Prog Clin Biol Res; 1982; 89():295-331. PubMed ID: 7051034
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound.
    Vermylen J; Chamone DA; Verstraete M
    Lancet; 1979 Mar; 1(8115):518-20. PubMed ID: 85106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
    Weichert W; Pauliks V; Breddin HK
    Haemostasis; 1983; 13(1):61-71. PubMed ID: 6132858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin treatment on prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Diabetologia; 1980 Jan; 18(1):65-8. PubMed ID: 6988267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of alpha-tocopherol on the development of diabetic angiopathy, platelet aggregation and status of the prostacyclin-thromboxane system in rats with streptozotocin diabetes].
    Zadkova GF; Avakian TIu; Markov KhM
    Probl Endokrinol (Mosk); 1993; 39(5):40-3. PubMed ID: 8108349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic rats.
    Robles RG; Villa E; Rábano A; Alvarez E; Martínez J; Ruilope LM; Sancho JM
    J Hypertens Suppl; 1993 Dec; 11(5):S208-9. PubMed ID: 8158348
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of prostaglandin modulators on prostate tumor growth and metastasis.
    Drago JR; Al-Mondhiry HA
    Anticancer Res; 1984; 4(6):391-4. PubMed ID: 6393859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.
    De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes.
    Moreno A; De La Cruz JP; Garcia Campos J; Sanchez De La Cuesta F
    Can J Ophthalmol; 1995 Apr; 30(3):117-23. PubMed ID: 7627895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes mellitus.
    de la Cruz JP; Moreno A; Sanchez de la Cuesta F; García Campos J
    Can J Ophthalmol; 1990 Dec; 25(7):329-32. PubMed ID: 2090335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptozotocin-induced diabetes in rat. I. Influence of hypertension and myocardial infarction on the development of vascular complications.
    Somova L; Dashev G; Kamenov V; Kirilov G; Kirjakov A; Doncheva M; Vassileva M
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):677-82. PubMed ID: 3221739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term streptozotocin-induced diabetes alters prostanoid production in rat aorta and mesenteric bed.
    Peredo HA; Rodríguez R; Susemihl MC; Villarreal I; Filinger E
    Auton Autacoid Pharmacol; 2006 Oct; 26(4):355-60. PubMed ID: 16968474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus.
    Quilley J; McGiff JC
    J Pharmacol Exp Ther; 1985 Jul; 234(1):211-6. PubMed ID: 3925127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stimulation by ethanol of rat aorta ring prostacyclin-like synthesis is related to the age of the animal.
    Adolfs MJ; Elliott GR
    Agents Actions Suppl; 1982; 11():217-24. PubMed ID: 6758551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of megavitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats.
    Gilbert VA; Zebrowski EJ; Chan AC
    Horm Metab Res; 1983 Jul; 15(7):320-5. PubMed ID: 6350138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.